This analysis has revealed that reduced levels of HP1α/CBX5 in monocytes from MS patients correlate with a range of transcriptional abnormalities all indicative of diminished Integrator complex (INTcom) activity. The gene discussed is CBX5; the disease is myeloid sarcoma.